Published in J Clin Pathol on September 01, 1993
Proliferation markers in tumours: interpretation and clinical value. J Clin Pathol (1998) 1.62
Apoptosis. The role of the endonuclease. Am J Pathol (1990) 5.43
Mathematical analysis of DNA distributions derived from flow microfluorometry. J Cell Biol (1974) 3.09
Analysis of PCP-data to determine the fraction of cells in the various phases of cell cycle. Radiat Environ Biophys (1975) 2.85
Comparative evaluation of several DNA binding dyes in the detection of apoptosis-associated chromatin degradation by flow cytometry. Cytometry (1992) 2.30
Algorithm for a DNA-cytophotometric diagnosis and grading of malignancy. Anal Quant Cytol (1984) 1.30
Comparative DNA analysis of solid tumors by flow cytometric and image analyses of touch imprints and flow cell suspensions. Am J Clin Pathol (1992) 1.12
Cytomorphometry. A methodologic study of preparation techniques, selection methods and sample sizes. Anal Quant Cytol Histol (1989) 0.87
Interrelation of formalin fixation, chromatin compactness and DNA values as measured by flow and image cytometry. Anal Quant Cytol Histol (1990) 0.83
Comparison between slide and flow cytophotometric DNA measurements in breast tumors. Anal Quant Cytol Histol (1987) 0.82
Quantitative DNA analysis in breast carcinomas: a comparison between image analysis and flow cytometry. Mod Pathol (1991) 0.81
Computer-aided S-phase fraction determination in DNA static cytometry in breast cancer. A preliminary methodologic study on cytologic material. Anal Quant Cytol Histol (1992) 0.80
Semi-automated diagnosis of cervical intra-epithelial neoplasia grade 2 by the measurement of acid labile DNA in cytologically normal nuclei. Cancer (1986) 0.80
Standardization of the Feulgen reaction for absorption DNA image cytometry: a review. Anal Cell Pathol (1991) 0.79
Defining the limits of DNA cytometry. Am J Clin Pathol (1992) 0.79
Ploidy pattern analysis. Statistical considerations. Anal Quant Cytol Histol (1985) 0.79
Test statistics for detecting aneuploidy and hyperdiploidy. Anal Quant Cytol Histol (1985) 0.79
Comparison between image and flow DNA cytometry in non-Hodgkin's lymphomas. Pathol Res Pract (1989) 0.78
DNA measurement errors with a scanning microdensitometer in cytologic and histologic samples of breast cancers. Anal Quant Cytol Histol (1991) 0.78
Expression of proliferating cell nuclear antigen in ameloblastomas and odontogenic cysts. Oral Oncol (1998) 1.52
Enhanced expression of transforming growth factor beta1 in rat thyroid hyperplasia is thyrotropin induced and time dependent. Eur J Endocrinol (1996) 1.41
Mucinous adenocarcinoma with superficial stromal invasion and villous adenoma of urachal remnants: a case report. J Clin Pathol (2003) 1.40
Vascular endothelial growth factor expression and capillary architecture in high-grade PIN and prostate cancer in untreated and androgen-ablated patients. Prostate (2000) 1.21
Pseudoneoplastic lesions of the testis and paratesticular structures. Virchows Arch (2007) 1.19
Integrin-dependent induction of functional urokinase receptors in primary T lymphocytes. J Clin Invest (1996) 1.06
Proliferation index of nonfunctioning pituitary adenomas: correlations with clinical characteristics and long-term follow-up results. Neurosurgery (2000) 1.05
Gastric dysplasia: a ten-year follow-up study. Pathol Res Pract (1994) 1.05
Prostatic intraepithelial neoplasia. Development of a Bayesian belief network for diagnosis and grading. Anal Quant Cytol Histol (1994) 1.02
Prostatic intraepithelial neoplasia (PIN). Performance of Bayesian belief network for diagnosis and grading. J Pathol (1995) 1.00
Unusual clinical presentation of a rare case of phyllodes tumor of the breast in an adolescent girl. J Pediatr Surg (2001) 0.97
P53 protein expression in odontogenic cysts. J Endod (2001) 0.96
Effects of complete androgen blockade for 12 and 24 weeks on the pathological stage and resection margin status of prostate cancer. J Clin Pathol (2002) 0.95
Subtle changes in benign tissue adjacent to prostate neoplasia detected with a Bayesian belief network. J Pathol (1997) 0.93
MRI and pathological examination of post-mortem brains: the problem of white matter high signal areas. Neuroradiology (1994) 0.91
Morphometric index of adult renal cell carcinoma. Comparison with the Fuhrman grading system. Virchows Arch (2000) 0.91
Vascular endothelial growth factor and microvessel density around healthy and failing dental implants. Int J Oral Maxillofac Implants (2001) 0.90
Prostatic intra-epithelial neoplasia: expression and location of proliferating cell nuclear antigen in epithelial, endothelial and stromal nuclei. Virchows Arch A Pathol Anat Histopathol (1993) 0.89
Biology, prognosis and response to therapy of breast carcinomas according to HER2 score. Ann Oncol (2008) 0.88
Analysis of the capillary architecture in the precursors of prostate cancer: recent findings and new concepts. Eur Urol (1996) 0.88
Basal cell hyperplasia and basal cell carcinoma of the prostate: a comprehensive review and discussion of a case with c-erbB-2 expression. J Clin Pathol (2005) 0.88
Morphological classification and definition of benign, preneoplastic and non-invasive neoplastic lesions of the urinary bladder. Histopathology (2008) 0.88
Determination of the proliferation and apoptotic index in adrenocorticotropin-secreting pituitary tumors : comparison between micro- and macroadenomas. Am J Pathol (2000) 0.87
Quantitative characterization of the frequency and location of cell proliferation and death in prostate pathology. J Cell Biochem Suppl (1994) 0.86
Morphological diagnosis of urothelial neoplasms. J Clin Pathol (2007) 0.86
Prostatic invasive adenocarcinoma. Effect of combination endocrine therapy (LHRH agonist and flutamide) on the expression and location of proliferating cell nuclear antigen (PCNA). Pathol Res Pract (1993) 0.85
Standardized mitotic counts in breast cancer. Evaluation of the method. Pathol Res Pract (1996) 0.85
Immunohistochemical evaluation of global DNA methylation and histone acetylation in papillary urothelial neoplasm of low malignant potential. Int J Immunopathol Pharmacol (2008) 0.85
Radioimmunoguided surgery using iodine-125-labeled biotinylated monoclonal antibodies and cold avidin. J Nucl Med (1994) 0.85
Is there a role for prostate tumour overexpressed-1 in the diagnosis of HGPIN and of prostatic adenocarcinoma? A comparison with alpha-methylacyl CoA racemase. Int J Immunopathol Pharmacol (2012) 0.85
Apoptosis in prostatic adenocarcinoma following complete androgen ablation. Urol Int (1998) 0.84
Perioperative anemia and blood transfusions as prognostic factors in patients undergoing resection for non-small cell lung cancers. Lung Cancer (2005) 0.84
Quantitative study of ductal breast cancer progression. A progression index (P.I.) for premalignant lesions and in situ carcinoma. Pathol Res Pract (1996) 0.84
Effect of total androgen ablation on pathologic stage and resection limit status of prostate cancer. Initial results of the Italian PROSIT study. Pathol Res Pract (1999) 0.84
Digital stereotactic biopsies for nonpalpable breast lesion. Surg Endosc (2003) 0.83
Transcontinental communication and quantitative digital histopathology via the Internet; with special reference to prostate neoplasia. J Clin Pathol (2002) 0.83
Microvessel density (MVD) and vascular endothelial growth factor expression (VEGF) in human oral squamous cell carcinoma. Anticancer Res (2001) 0.83
Usefulness of markers of cell proliferation in the management of pituitary adenomas. Clin Sci (Lond) (1998) 0.82
Evaluation of prostatic intraepithelial neoplasia after treatment with a 5-alpha-reductase inhibitor (finasteride). A methodologic approach. Anal Quant Cytol Histol (1996) 0.82
Reproducibility of mitotic counts and identification of mitotic figures in malignant glial tumors. Appl Pathol (1988) 0.82
The expression of alpha v, alpha 5, beta 1, and beta 3 integrin chains on ejaculated human spermatozoa varies with their functional state. Mol Hum Reprod (1996) 0.82
Effect of complete androgen blockade on pathologic stage and resection margin status of prostate cancer: progress pathology report of the Italian PROSIT study. Urology (2001) 0.81
Centrocytic-like lymphoma associated with localized amyloidosis of the large intestine. Virchows Arch (1994) 0.81
Subtle morphological and molecular changes in normal-looking epithelium in prostates with prostatic intraepithelial neoplasia or cancer. Eur Urol (1999) 0.81
bcl-2 expression and apoptotic bodies in 13-cis-retinoic acid (isotretinoin)-topically treated oral leukoplakia: a pilot study. Oral Oncol (1999) 0.81
Machine vision-based histometry of premalignant and malignant prostatic lesions. Pathol Res Pract (1995) 0.81
Occurrence of cell death (apoptosis) in prostatic intra-epithelial neoplasia. Virchows Arch A Pathol Anat Histopathol (1993) 0.81
Serum markers for monitoring of prostatic carcinoma. Prostate (1997) 0.81
Prostatic intra-epithelial neoplasia. Qualitative and quantitative analyses of the blood capillary architecture on thin tissue sections. Pathol Res Pract (1993) 0.81
Long-term follow-up in early gastric cancer: evaluation of prognostic factors. J Pathol (1995) 0.80
Early recognition of a discordant xenogeneic organ by human circulating lymphocytes. J Immunol (1992) 0.80
Nerve regeneration through a combined autologous conduit (vein plus acellular muscle grafts). Biomaterials (1998) 0.80
Texture image analysis in differentiating malignant from benign adrenal cortical tumors in children and adults. Anticancer Res (2009) 0.80
Cytometric evidence that cervical intraepithelial neoplasia I and II are dysplasias rather than true neoplasias. An image analysis study of factors involved in the progression of cervical lesions. Anal Quant Cytol Histol (1992) 0.80
Computer-aided S-phase fraction determination in DNA static cytometry in breast cancer. A preliminary methodologic study on cytologic material. Anal Quant Cytol Histol (1992) 0.80
Changes produced in the urothelium by traditional and newer therapeutic procedures for bladder cancer. J Clin Pathol (2002) 0.80
Androgen-deprived prostate adenocarcinoma: evaluation of treatment-related changes versus no distinctive treatment effect with a Bayesian belief network. A methodological approach. Eur Urol (1996) 0.80
Update on selected renal cell tumors with clear cell features. With emphasis on multilocular cystic clear cell renal cell carcinoma. Histol Histopathol (2013) 0.79
Assessment of radical prostatectomy specimens and diagnostic reporting of pathological findings. Pathologica (2001) 0.79
Aneuploidy and nuclear features of prostatic intraepithelial neoplasia (PIN). J Cell Biochem Suppl (1992) 0.79
Nuclear changes in the normal-looking columnar epithelium adjacent to and distant from prostatic intraepithelial neoplasia and prostate cancer. Morphometric analysis in whole-mount sections. Virchows Arch (2000) 0.79
Diagnostic decision support for prostate lesions. Pathol Res Pract (1995) 0.79
Meningeal carcinomatosis from transitional cell carcinoma of the bladder: report of two cases and review of the literature. Cancer Invest (1999) 0.79
HSP70 is selectively over-expressed in the blast cells of the germinal centres and paracortex in reactive lymph nodes. Histopathology (2001) 0.79
Extraskeletal osteosarcoma of the mediastinum associated with long-term patient survival. A case report. Anticancer Res (1996) 0.79
Correlation between clinical characteristics and proliferative activity in patients with craniopharyngioma. J Neurol Neurosurg Psychiatry (2004) 0.78
Evolution of the changes of the ileal pouch mucosa over a long follow-up period. Hepatogastroenterology (2003) 0.78
Quantitative study of ductal breast cancer progression. Morphometric evaluation of phenotypical changes occurring in benign and preinvasive epithelial lesions. Pathol Res Pract (1994) 0.78
Immunohistochemical expression and localization of somatostatin receptor subtypes in prostate cancer with neuroendocrine differentiation. Int J Immunopathol Pharmacol (2010) 0.78
Intrinsic third ventricle craniopharyngiomas with normal pressure hydrocephalus. Neurochirurgia (Stuttg) (1980) 0.78
Subarachnoid haemorrhage due to widely metastatising malignant ependymoma. Neurochirurgia (Stuttg) (1985) 0.78
Effects of octreotide treatment on the proliferation and apoptotic index of GH-secreting pituitary adenomas. J Clin Endocrinol Metab (2001) 0.78
Avidin-biotin system in radioimmunoguided surgery for colorectal cancer. Advantages and limits. Dis Colon Rectum (1994) 0.78
The number of nucleoli in benign and malignant thyroid lesions: a useful diagnostic sign in cytological preparations. Cytopathology (1990) 0.78
Quantitation of the prostatic intra-epithelial neoplasia. Analysis of the nucleolar size, number and location. Pathol Res Pract (1991) 0.78
Color Doppler sonography patterns related to histological findings in Graves' disease. Thyroid (1998) 0.77
Global acetylation and methylation changes predict papillary urothelial neoplasia of low malignant potential recurrence: a quantitative analysis. Int J Immunopathol Pharmacol (2011) 0.77
Immunohistochemical expression and localization of somatostatin receptors in normal prostate, high grade prostatic intraepithelial neoplasia and prostate cancer and its many faces. J Biol Regul Homeost Agents (2012) 0.77
Reproducibility of histopathologic tumor grading in penile cancer--results of a European project. Virchows Arch (2014) 0.77
Putative tissue markers in prostate cancer*. Urologia (2010) 0.77